{"id":"W2093363596","doi":"10.1158/1538-7445.prca2012-a16","title":"Abstract A16: A phase I/II clinical trial of a MUC1-glycopeptide dendritic cell vaccine in castrate resistant non-metastatic prostate cancer patients","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Hamilton Health Sciences; Université Laval","funders":"","keywords":"Medicine; MUC1; Glycopeptide; Peptide vaccine; Immunotherapy; Cancer vaccine; Antigen; Epitope; Clinical trial; Immune system; Internal medicine; Vaccination; Immunology; Oncology; Microbiology; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001068117,0.001490338,0.001620483,0.0003463307,0.0003763994,0.0008587537,0.0009116416,0.001236967,0.004008438],"category_scores_gemma":[0.0005563677,0.0005292007,0.0009142781,0.0003160266,0.0008879636,0.0006224072,0.0003797135,0.002969152,0.001023783],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005623501,"about_ca_system_score_gemma":0.001652858,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008029871,"about_ca_topic_score_gemma":0.0009505289,"domain_scores_codex":[0.999734,0.00009860796,0.00001544191,0.00005052532,0.00003018717,0.0000711893],"domain_scores_gemma":[0.9995123,0.00004733872,0.00007298846,0.00004410599,0.00003698953,0.0002863045],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5248041,0.181797,0.004884975,0.00209447,0.0008919112,0.0008908766,0.0005153481,0.004032602,0.1786942,0.0004541764,0.005327371,0.09561297],"study_design_scores_gemma":[0.3058324,0.6798649,0.003747942,0.00003392094,0.0001460811,0.0002653718,0.00003444812,0.0008560169,0.007073117,0.0001186526,0.002009117,0.00001810919],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9915733,0.001221274,0.0005654956,0.0003923981,0.0002031241,0.004203164,0.0008063923,0.000106375,0.0009285118],"genre_scores_gemma":[0.9829447,0.001497309,0.002021303,0.0007749949,0.0002394715,0.00483815,0.002149466,0.00003598883,0.005498565],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004008438,"threshold_uncertainty_score":0.01340955,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08959077077601033,"score_gpt":0.4469349705692383,"score_spread":0.357344199793228,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}